ATC code D05
In this article, we will delve into the fascinating world of ATC code D05, exploring its multiple facets and meanings. From a historical to a contemporary approach, we will analyze how ATC code D05 has left its mark on different aspects of society. Through research and testimonies, we will reveal the different perspectives that exist around ATC code D05, allowing the reader to obtain a broad and enriching vision on this topic. From its origins to its impact today, we will immerse ourselves in a journey of discovery and reflection about ATC code D05.
| ATC code D: Dermatologicals |
|---|
|
| ATCvet only |
| Other ATC codes |
ATC code D05 Antipsoriatics is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup D05 is part of the anatomical group D Dermatologicals.[4]
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QD05.[5]
National versions of the ATC classification may include additional codes not present in this list, which follows the WHO version.
In ATCvet, this subgroup is named "QD05 Drugs for keratoseborrheic disorders".
D05A Antipsoriatics for topical use
- In ATCvet, this subgroup is named "QD05A Drugs for keratoseborrheic disorders, topical use".
D05AA Tars
D05AC Antracen derivatives
- D05AC01 Dithranol
- D05AC51 Dithranol, combinations
D05AD Psoralens for topical use
- D05AD01 Trioxysalen
- D05AD02 Methoxsalen
D05AX Other antipsoriatics for topical use
- In ATCvet, this subgroup is named "QD05AX Other drugs for keratoseborrheic disorders for topical use".
- D05AX01 Fumaric acid
- D05AX02 Calcipotriol
- D05AX03 Calcitriol
- D05AX04 Tacalcitol
- D05AX05 Tazarotene
- D05AX06 Roflumilast
- D05AX07 Tapinarof
- D05AX52 Calcipotriol, combinations
- D05AX55 Tazarotene and ulobetasol
D05B Antipsoriatics for systemic use
- In ATCvet, this subgroup is named "QD05B Drugs for keratoseborrheic disorders, systemic use".
D05BA Psoralens for systemic use
- D05BA01 Trioxysalen
- D05BA02 Methoxsalen
- D05BA03 Bergapten
- D05BB01 Etretinate
- D05BB02 Acitretin
D05BX Other antipsoriatics for systemic use
- In ATCvet, this subgroup is named "QD05BX Other drugs for keratoseborrheic disorders for systemic use".
- D05BX51 Fumaric acid derivatives, combinations
References
- ^ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
- ^ "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
- ^ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
- ^ "ATC/DDD Index 2022: code D05". WHO Collaborating Centre for Drug Statistics Methodology.
- ^ "ATCvet Index 2022: code QD05". WHO Collaborating Centre for Drug Statistics Methodology.